/

Press Release

Leclanché Shareholders Approve All Board Proposals at the Annual General Meeting

Yverdon-les-Bains, Switzerland, April 3, 2014 - Leclanché S.A. (SIX Swiss Exchange: LECN), specialized in the production of large-format lithium-ion cells and energy storage solutions, announced today that shareholders approved all the resolutions proposed by the Board of Directors at its 2014 annual general meeting held today in Yverdon-les-Bains, including the annual report and statutory financial statements and the proposed capital reduction/increase (see below). The capital increase approved is pursuant to the election by Precept to convert part of its loan into ordinary shares of the company and does not result in any new cash. Mr Jim Atack was confirmed by shareholders as Chairman of the Leclanché Board of Directors as well as all other members who have stood for annual re-election.

Shareholders of Leclanché S.A. approved in particular:

- a reduction of the share capital of the company of CHF 8,158,607.87 by way of par value reduction from currently CHF 2.11 to CHF 1.50 per share

- an ordinary capital increase of CHF 10,703,782.50 through the issuance of 7,135,855 new registered shares with a nominal value of CHF 1.50 for the conversion of the Precept loan;

- the re-elections to the Board of Directors of Messrs Jim Atack, Stefan A. Müller, Antoine Spillmann and Bryan Urban

- the election of Mr Jim Atack as Chairman of the Board and the elections to the Remuneration Committee of Messrs Jim Atack, Stefan A. Müller and Bryan Urban, as well as the election of the Independent Proxy.

- the consequential amendments to the Articles of Association.

The Board will proceed shortly to implement the capital Increase and file the necessary registrations in the commercial register. The issuance of 7,135,855 new shares, will bring the number of shares in issue to 20,510,622. Following the acceptance of the proposed capital increase and the conversion of the Precept loan into shares, Precept will hold 10,278,240 shares representing 50.1% of the issued share capital of Leclanché SA.

About Leclanché

Leclanché's strategy is to become one of the leading lithium-ion cell producers and solution providers for energy storage systems in Europe. Its strategic priorities are to develop and market energy storage products for home, industrial markets and grid applications and to grow its existing businesses of developing portable energy storage systems for military, medical and industrial applications. It also includes providing a range of professional energy storage systems to a diversified customer base. Through participation in research consortia focusing on hybrid and E-mobility applications, Leclanché is positioned to take advantage of new market opportunities.

Through a unique, patented ceramic separator technology and focus on lithium-titanate technology, Leclanché manufactures large-format lithium-ion cells, optimized for safety and cycle-life, in a fully automated production process. The newly installed production line will have an annual capacity of one million cells or 76 MWh.

Leclanché was founded in 1909 in Yverdon-les-Bains. Through the integration of a spin-off from the Fraunhofer-Gesellschaft in 2006, the company evolved from a traditional battery manufacturer to become a leading developer and manufacturer of lithium-ion cells in Europe. Leclanché currently employs more than 100 staff and is listed on the SIX Swiss Exchange (LECN). The company has its headquarters in Yverdon-les-Bains (Switzerland) and production facilities in Willstätt (Germany).

www.leclanche.eu

Media contact:

Christophe Lamps, Dynamics Group S.A.: Telephone: +41 79 476 26 87, cla@dynamicsgroup.ch

Disclaimer

This press release contains certain forward-looking statements relating to Leclanché's business, which can be identified by terminology such as "strategic", "proposes", "to introduce", "will", "planned", "expected", "commitment", "expects", "set", "preparing", "plans", "estimates", "aims", "would", "potential", "awaiting", "estimated", "proposal", or similar expressions, or by expressed or implied discussions regarding the ramp up of Leclanché's production capacity, potential applications for existing products, or regarding potential future revenues from any such products, or potential future sales or earnings of Leclanché or any of its business units. You should not place undue reliance on these statements. Such forward-looking statements reflect the current views of Leclanché regarding future events, and involve known and unknown risks, uncertainties and other factors that may cause actual results to be materially different from any future results, performance or achievements expressed or implied by such statements. There can be no guarantee that Leclanché's products will achieve any particular revenue levels. Nor can there be any guarantee that Leclanché, or any of the business units, will achieve any particular financial results.